(Q34066243)

30 July 2017

1 reference

title

Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor (English)

1 reference

30 July 2017

Anti-folate resistance in leukemia: treatment with “high-dose” methotrexate and citrovorum factor (English)

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

author name string

R. A. Bender

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1104164

22 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1104164

22 September 2023

publication date

1 September 1975

1 reference

full work available at URL

30 July 2017

https://api.elsevier.com/content/article/PII:S0305737275800041?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

https://api.elsevier.com/content/article/PII:S0305737275800041?httpAccept=text/plain

22 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

published in

Cancer Treatment Reviews

1 reference

30 July 2017

volume

2

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

215-224

1 reference

Methotrexate Pharmacokinetics

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Effects of large infrequent doses of a-methopterin on acute leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Continuous infusion of methotrexate in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Effect of anti-leukemic drugs on cell cycle of human leukemic blast cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

The characteristics of the membrane transport of amethopterin and the naturally occurring folates

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Hepatotoxic effects of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Pharmacokinetics of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

METHOTREXATE DISPLACEMENT IN MAN.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Studies on drug transport by normal human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Uptake as a Determinant of Methotrexate Response in Mouse Leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Synchronization and recruitment in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

The effect of organic acids on renal clearance of methotrexate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Comparison of the Proliferative Capacity of Acute Leukæmia Cells in Bone Marrow and Blood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Increased dihydrofolate reductase activity as a possible basis of drug resistance in leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Triamterene-induced elevation of dihydrofolate reductase activity in human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

Toxic and therapeutic effects of methotrexate-folinic acid (Leucovorin) in advanced cancer and leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2875%2980004-1

7 January 2021

1

32

1539

Albrecht

1972

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

2

35

1305

Bender

1975

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

3

23

1286

Bertino

1963

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

4

30

2372

Bertino

1970

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

8

30

1782

Capizzi

1970

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

20

30

2132

Gottlieb

1970

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

23

25

1018

Henderson

1965

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

25

33

521

Hoovis

1973

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

33

28

564

Kessel

1968

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

38

33

1729

Levitt

1973

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

41

28

1088

Mitchell

1968

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

45

29

166

Roberts

1969

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

46

28

1955

Roberts

1968

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

49

32

2120

Sirotnak

1972

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

51

33

2014

Vadlamudi

1973

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

53

33

1670

Zager

1973

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(75)80004-1

22 September 2023

Identifiers

1 reference

30 July 2017

1 reference